The study by Lennon et al. indicated a role of EphB4-EphrinB2 in the treatment of resistance to radiotherapy in pancreatic ductal adenocarcinoma [29]. The gene discussed is EPHB4; the disease is pancreatic ductal adenocarcinoma.